Guidelines for Management of Severe Hypokalemia

Indications for Intravenous Potassium Replacement

Target Serum Potassium Levels

Potassium Replacement in Diabetic Ketoacidosis

Magnesium Co‑replacement

Renal Function Considerations

Medication Adjustments

Safety Precautions

Potassium Replacement Recommendations for Hypokalemia

Intravenous Replacement in Diabetic Ketoacidosis

When renal function is confirmed, potassium‑containing intravenous fluids for diabetic ketoacidosis should provide 20–30 mEq/L of potassium, typically composed of two‑thirds potassium chloride and one‑third potassium phosphate. 7, 8, 9

Oral Potassium Chloride Dosing

Administer 40–60 mEq of potassium chloride orally in divided doses to patients with mild‑to‑moderate hypokalemia who are hemodynamically stable and have a functional gastrointestinal tract. 10

Potassium chloride is preferred over dietary supplementation because diet alone rarely restores adequate serum levels. 10

Target Serum Potassium Range

Aim to raise serum potassium to a target of 4.0–5.0 mEq/L in patients undergoing replacement therapy. 11, 10, 12

Renal Function Assessment and Dose Adjustment

Assess renal function (e.g., estimated glomerular filtration rate) before initiating potassium replacement; adjust the dose in patients with impaired renal function to prevent hyperkalemia. 13, 14, 15

Patients with eGFR 40–70 mL/min/1.73 m² are less likely to achieve target potassium after a single dose compared with those with eGFR > 70 mL/min/1.73 m². 13, 14

Interaction with Aldosterone Antagonists and ACE Inhibitors

Discontinue or reduce oral potassium supplements when starting aldosterone antagonists, and monitor closely for hyperkalemia when potassium‑sparing agents are combined with ACE inhibitors or ARBs. 13, 15, 10

Magnesium Monitoring

Check serum magnesium concurrently with potassium replacement; correct hypomagnesemia (serum magnesium < 1.6 mEq/L) because low magnesium impairs potassium repletion. 10, 12

Target Serum Potassium Range and Medication Interactions in Mild Hypokalemia

Desired Serum Potassium Range

In otherwise healthy adults, a serum potassium concentration of 4.0–5.0 mEq/L is recommended to minimize the risk of arrhythmias, especially when the patient may later receive digitalis or anti‑arrhythmic agents. 16
Maintaining potassium at or above 4.0 mEq/L has been associated with a lower incidence of cardiac adverse events in populations at risk for digitalis toxicity. 17

Medication‑Related Considerations

Initiation of aldosterone antagonists (e.g., spironolactone, eplerenone) or ACE inhibitors should be accompanied by a reassessment of potassium supplementation, with dose reduction or discontinuation to prevent hyper‑kalemia. [18][19]
When hypokalemia is attributable to potassium‑wasting diuretics (e.g., thiazides), clinicians should consider dose reduction or substitution with a potassium‑sparing alternative after serum potassium repletion. 19